Speaker illustration

undefined undefined undefined

The ARAMIS trial - Allopurinol in patients with Refractory Angina to iMprove Ischemic Symptoms

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Inflammation in chronic coronary syndromes

Thumbnail

ESC 365 is supported by